News

Hixny Enhances Patient Care in New York with Vital Alerts

Hixny Enhances Patient Care in New York with Vital Alerts

Hixny's New Initiative to Enhance Healthcare Alerts

Hixny has proudly announced a new partnership with the Statewide Health Information Network for New York (SHIN-NY), aimed at promptly making patient encounter alerts accessible to healthcare providers and insurers throughout the state. This significant upgrade is built upon an already reliable service, which has been serving thousands of Hixny's existing health information exchange users effectively for several years.

Understanding the Benefits of the Alert System

The SHIN-NY Statewide Encounter Alerts, powered by Hixny, enables healthcare providers to receive vital notifications regardless of their involvement with Hixny. This innovative approach ensures that notification systems operate independently from existing health information exchange connections. Therefore, providers can opt-in to receive alerts even if they are linked to another HIE as their primary connection. Patients are not required to provide any additional consent, simplifying the process significantly.

CEO Insights on the New Contract

Mark McKinney, the CEO of Hixny, expressed enthusiasm regarding the recent contract awarded by SHIN-NY. He stated: "For over 25 years, we have been working diligently to streamline how the healthcare community delivers knowledge-driven, evidence-based patient care. The implementation of our alert capabilities marks another important stride toward enhancing the transitions of care statewide."

Why Choose Hixny's Alerting Services?

Hixny’s alert service maintains the existing workflow of healthcare providers, enabling them to choose their preferred delivery method for alerts. The service is compatible with all major electronic health record (EHR) systems, including widely used platforms such as Athena, eCW, EPIC, Cerner, MEDENT, Meditech, and NextGen, although this is not an exhaustive list. This flexibility allows for a seamless integration into providers’ current practices.

Streamlining Alerts to Enhance Efficiency

Moreover, Hixny’s solution minimizes unnecessary notifications, which enables providers to receive alerts specifically for their patient panel that has been admitted to or discharged from ER or inpatient care. This tailored approach helps healthcare professionals focus on what matters most without overwhelming them with irrelevant information.

Upholding Security Standards

All alerts are crafted with leading security standards in mind, ensuring compliance and safety at the state level. This dedication to security is crucial as the healthcare industry continues to evolve and digitize patient information.

Adapting to Changes in the SHIN-NY Structure

Historically, every community HIE, also known as qualified entities (QEs) or regional health information organizations (RHIOs), received state funding to offer core services. However, going forward, SHIN-NY plans to streamline service provision, allowing a select number of HIEs to provide specific services. Hixny, being one of the chosen HIEs, will continue to deliver the critical patient encounter alerts.

Cost Structure for Providers and Insurers

Providers who cater to Medicaid patients will access all alerts for free through Hixny. For those who do not accept Medicaid, a nominal system access fee applies. Health insurers can receive alerts for Medicaid members at no cost; however, a minimal fee will be incurred for alerts regarding non-Medicaid members. Interested parties can contact Bryan Cudmore, Hixny's Vice President of Account Management, to enroll in this invaluable alert service at bcudmore@hixny.org.

About Hixny

Hixny operates as a nonprofit electronic health information exchange (HIE) dedicated to enhancing the flow of patient data within the healthcare system. By leveraging nationally recognized technologies, Hixny aims to facilitate secure and efficient patient record exchanges, enabling healthcare teams and public health officials to access actionable information in real-time. This integration leads to improved care quality while minimizing workflow complexities and costs. Hixny proudly serves the state as an established qualified entity of the SHIN-NY.

For media inquiries, contact Katie See, Director of Marketing & Communications at ksee@hixny.org or call 518.243.9631. For more information about Hixny, visit Hixny.org.

Frequently Asked Questions

What is Hixny's new initiative about?

Hixny's new initiative focuses on providing patient encounter alerts statewide to healthcare providers and health insurers, enhancing communication and care coordination.

How do alerts work?

The alerts system allows providers to receive notifications independent of their current HIE affiliations, streamlining the process for better patient care.

What are the benefits of using Hixny's alert system?

Providers enjoy flexibility in how they receive alerts, compatibility with various EHR systems, and reduced unnecessary notifications for patient care.

Are there any costs associated with the alert system?

Medicaid providers can access alerts for free, while others may incur nominal fees based on their patient population.

How can providers enroll for alerts?

Providers interested in enrolling for alerts can contact Bryan Cudmore at the provided email address for assistance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 184

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 136

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 184

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 295

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 153

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 168

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 132

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading

Top 5 Most Recently Viewed Articles

Telenor Group's Q3 2024 Results: Join Us for Insights

Updated Category News Views 304

Join Telenor Group for a Detailed Overview of Q3 2024 Results Telenor Group invites you to participate in the forthcoming results announcement for the third quarter of 2024. This event is an exciting opportunity to gain crucial insights into the company's performance and strategic direction. Details of the Presentation The presentation is scheduled for a morning session,...

Continue Reading
Azafaros Secures Key Approvals for Phase 3 Trials of Nizubaglustat

Updated Category News Views 322

Azafaros Achieves Critical Milestones in Regulatory Approvals Azafaros B.V. has recently announced significant advancements regarding its lead asset, nizubaglustat, which has garnered orphan drug designation from both United States and European regulatory authorities. This designation is specifically for the treatment of GM1 gangliosidosis, a rare lysosomal storage...

Continue Reading
Refresco's Leadership Changes Set the Stage for Future Growth

Updated Category News Views 373

Refresco's Leadership Changes Set the Stage for Future Growth Refresco, a prominent independent beverage solutions provider, recently announced that its Chief Executive Officer, Hans Roelofs, will be retiring. This transition marks a significant moment not only for Hans but also for the company, which has been under his stewardship for nearly two decades. Hans Roelofs: A...

Continue Reading
How a $1000 Investment in Home Depot Would Have Grown

Updated Category News Views 148

Home Depot: A Strong Investment Choice Home Depot has proven itself as a robust performer in the stock market over the years. With an impressive market capitalization of $379.06 billion, it has outshone the market by approximately 6.8% annually. The average annual return of 19.17% that the company has generated is nothing short of remarkable. This growth exemplifies the...

Continue Reading
AI Stocks Face Market Correction Amid Recovery Clouds

Updated Category News Views 207

The Shift in AI Stock Momentum The exhilarating rally that captivated investors in the spring is now showing signs of fatigue. What we're witnessing is not merely a dip, but a significant reality check across global markets. Japanese indices experienced dramatic declines, with the Nikkei plummeting over 4%—its steepest single-day drop in recent memory. Traders are...

Continue Reading